-
51تقرير
المصدر: Information från Läkemedelsverket. 11(6):47
-
52دورية أكاديمية
المؤلفون: Nyberg, Gunnar
المصدر: Medicinsk Access. 7(3):15
-
53دورية أكاديمية
المؤلفون: Burnier, M., Kjeldsen, S.E., Narkiewicz, K., Oparil, S.
المصدر: Blood pressure, vol. 29, no. 2, pp. 68-69
مصطلحات موضوعية: Angiotensin II Type 1 Receptor Blockers/adverse effects, Antihypertensive Agents/adverse effects, Celiac Disease/chemically induced, Celiac Disease/diagnosis, Celiac Disease/epidemiology, Humans, Hypertension/drug therapy, Incidence, Olmesartan Medoxomil/adverse effects, Patient Safety, Risk Assessment, Risk Factors
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32049554; info:eu-repo/semantics/altIdentifier/eissn/1651-1999; https://serval.unil.ch/notice/serval:BIB_BBB2637A58E4Test; urn:issn:0803-7051
الإتاحة: https://doi.org/10.1080/08037051.2020.1726101Test
https://serval.unil.ch/notice/serval:BIB_BBB2637A58E4Test -
54دورية أكاديمية
المساهمون: Choon Ok Kim, Hae Wan Lee, Eun Sil Oh, Sook Jin Seong, Do Young Kim, Joomi Lee, Sang-Hoon Ahn, Young-Ran Yoon, Chang-Min Cho, Min Soo Park, Kim, Do Young, Park, Min Soo, Ahn, Sang Hoon
مصطلحات موضوعية: Adult, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/blood, Angiotensin II Type 1 Receptor Blockers/pharmacokinetics, Antihypertensive Agents/adverse effects, Antihypertensive Agents/blood, Antihypertensive Agents/pharmacokinetics, Biological Availability, Biphenyl Compounds/adverse effects, Biphenyl Compounds/blood, Biphenyl Compounds/pharmacokinetics, Blood Pressure/drug effects, Half-Life, Heart Rate/drug effects, Hepatic Insufficiency/blood, Hepatic Insufficiency/metabolism, Hepatic Insufficiency/physiopathology, Humans, Liver/drug effects, Liver/physiopathology, Male, Metabolic Clearance Rate, Middle Aged, Pyrimidines/adverse effects, Pyrimidines/blood, Pyrimidines/pharmacokinetics, Republic of Korea, Severity of Illness Index, Tetrazoles/adverse effects, Tetrazoles/blood
العلاقة: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; J01296; OAK-2013-03137; https://ir.ymlib.yonsei.ac.kr/handle/22282913/89251Test; http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00005344-201312000-00004&LSLINK=80&D=ovftTest; T201305833; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, Vol.62(6) : 524-529, 2013
الإتاحة: https://doi.org/10.1097/FJC.0000000000000010Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89251Test
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00005344-201312000-00004&LSLINK=80&D=ovftTest -
55مؤتمر
-
56دورية أكاديمية
-
57دورية أكاديمية
المؤلفون: Mathiesen, E R, Johansen, M, Kamper, A L, Damm, P
المصدر: Ugeskrift for Laeger. 171(25):2094
-
58دورية أكاديمية
المؤلفون: Fastbom, J
المصدر: Nordisk Geriatrik. 12(3):28
-
59دورية أكاديمية
المساهمون: Ji Young Oh, Se Jin Park, Jae II Shin, Shin, Jae Il
مصطلحات موضوعية: Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Dose-Response Relationship, Drug, Humans, Hydralazine*/administration & dosage, Hydralazine*/adverse effects, Hypertension/drug therapy, Interleukin-10/immunology, Lupus Erythematosus, Systemic*/chemically induced, Systemic*/immunology
العلاقة: JOURNAL OF CLINICAL HYPERTENSION; J01320; OAK-2012-03121; https://ir.ymlib.yonsei.ac.kr/handle/22282913/90687Test; T201206048; JOURNAL OF CLINICAL HYPERTENSION, Vol.14(12) : 887, 2012
-
60دورية أكاديمية
المساهمون: Bum-Kee Hong, Chang Gyu Park, Ki Sik Kim, Myeong Ho Yoon, Ho Joong Yoon, Jeong Han Yoon, Joo Young Yang, Young Jin Choi, Prof. Seung Yun Cho, Cho, Seung Yun, Hong, Bum Kee
مصطلحات موضوعية: Adult, Amlodipine/administration & dosage, Amlodipine/adverse effects, Amlodipine/therapeutic use, Angiotensin II Type 1 Receptor Blockers/administration & dosage, Angiotensin II Type 1 Receptor Blockers/adverse effects, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Antihypertensive Agents/administration & dosage, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Blood Pressure/drug effects, Calcium Channel Blockers/administration & dosage, Calcium Channel Blockers/adverse effects, Calcium Channel Blockers/therapeutic use, Double-Blind Method, Drug Combinations, Female, Humans, Hypertension/drug therapy, Hypertension/physiopathology, Losartan/administration & dosage, Losartan/adverse effects, Losartan/therapeutic use, Male, Middle Aged, Republic of Korea, Time Factors, Treatment Outcome, Diastolic Blood Pressure, Losartan
العلاقة: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS; J00072; OAK-2012-01470; https://ir.ymlib.yonsei.ac.kr/handle/22282913/89411Test; http://link.springer.com/article/10.2165%2F11597410-000000000-00000Test; T201202935; AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, Vol.12(3) : 189-195, 2012